| dc.contributor.author | Agachi, Svetlana | |
| dc.contributor.author | Popa, Serghei | |
| dc.contributor.author | Rotaru, Larisa | |
| dc.contributor.author | Russu, Eugeniu | |
| dc.contributor.author | Dutca, Lucia | |
| dc.contributor.author | Meleșco, Irina | |
| dc.contributor.author | Stog, Valeria | |
| dc.date.accessioned | 2025-07-23T08:11:20Z | |
| dc.date.available | 2025-07-23T08:11:20Z | |
| dc.date.issued | 2025 | |
| dc.identifier.citation | AGACHI, Svetlana; Serghei POPA; Larisa ROTARU; Eugeniu RUSSU; Lucia DUTCA; Irina MELEȘCO and Valeria STOG. COVID-19 as a possible risk factor for poor prognosis in systemic sclerosis. In: Revista de Ştiinţe ale Sănătăţii din Moldova = Moldovan Journal of Health Sciences. 2025, vol. 12, nr. 2, pp. 71-74. ISSN 2345-1467. DOI: https://doi.org/10.52645/MJHS.2025.2.10 | en_US |
| dc.identifier.issn | 2345-1467 | |
| dc.identifier.uri | https://doi.org/10.52645/MJHS.2025.2.10 | |
| dc.identifier.uri | https://repository.usmf.md/handle/20.500.12710/30965 | |
| dc.identifier.uri | https://cercetare.usmf.md/sites/default/files/2025-06/MJHS_12_2_2025.pdf | |
| dc.description.abstract | Introduction. Scleroderma Renal Crisis (SRC) is a life-threatening complication of systemic sclerosis (SSc), traditionally associated with anti-RNA polymerase III antibodies, corticosteroid use, and diffuse skin involvement. However, the role of COVID-19 as a potential trigger for SRC remains poorly understood. This study explores the occurrence of COVID-19-associated SRC, focusing on its clinical presentation, underlying risk factors, and outcomes. Case presentation. We present a case series of two unvaccinated patients with systemic sclerosis who developed SRC following COVID-19 infection, despite the absence of traditional risk factors. Clinical features, laboratory findings, renal histopathology, and disease progression were analyzed to assess potential mechanisms linking SARS-CoV-2 infection to SRC onset. Both patients developed abrupt-onset malignant hypertension and acute kidney injury after supporting the COVID-19. Neither patient had a history of corticosteroid use or known anti-RNA polymerase III positivity, suggesting an alternative mechanism of SRC activation. Notably, both cases had pre-existing renal anomalies (renal developmental abnormality and prior nephrectomy), which may have contributed to increased susceptibility. Despite aggressive management, both patients developed dialysis-dependent renal failure and succumbed to SRC-related complications. Conclusions. Our findings highlight COVID-19 as a potential trigger for SRC, possibly through endothelial dysfunction, inflammatory cytokine storms, and renal microangiopathy. The presence of pre-existing kidney conditions may further predispose SSc patients to SRC following SARS-CoV-2 infection. Additionally, the lack of vaccination in these cases raises the question of whether COVID-19 immunization could reduce SRC risk. Further research is needed to elucidate the pathophysiology, risk stratification, and long-term outcomes of COVID-19-associated SRC, as well as the role of vaccination in prevention. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova | en_US |
| dc.relation.ispartof | Revista de Științe ale Sănătății din Moldova = Moldovan Journal of Health Sciences | en_US |
| dc.subject | COVID-19 | en_US |
| dc.subject | scleroderma renal crisis | en_US |
| dc.subject | systemic sclerosis | en_US |
| dc.subject | acute kidney injury | en_US |
| dc.subject | SARS-CoV-2 | en_US |
| dc.subject.ddc | UDC: 616.98:578.834.1:[616-004.1+616.61-008.64] | en_US |
| dc.title | COVID-19 as a possible risk factor for poor prognosis in systemic sclerosis | en_US |
| dc.type | Article | en_US |